Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0056 | 0.0456 | 0.0909 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.0056 | 0.0456 | 0.7805 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | 0.0134 | 0.2834 | 0.2492 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.0386 | 0.6615 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.0056 | 0.0456 | 0.7805 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.0056 | 0.0456 | 0.7805 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0056 | 0.0456 | 0.7805 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0193 | 0.4652 | 0.4396 |
Brugia malayi | ecdysteroid receptor | 0.0056 | 0.0456 | 0.7805 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0056 | 0.0456 | 0.0909 |
Echinococcus multilocularis | tumor protein p63 | 0.0367 | 1 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.0056 | 0.0456 | 0.7805 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.0056 | 0.0456 | 0.7805 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0137 | 0.2934 | 0.2596 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | steroid hormone receptor | 0.0056 | 0.0456 | 0.7805 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0163 | 0.3742 | 0.7463 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0584 | 1 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.0056 | 0.0456 | 0.7805 |
Schistosoma mansoni | nuclear hormone receptor | 0.0056 | 0.0456 | 0.0909 |
Brugia malayi | nuclear hormone receptor | 0.0056 | 0.0456 | 0.7805 |
Schistosoma mansoni | hypothetical protein | 0.0137 | 0.2934 | 0.5852 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.0056 | 0.0456 | 0.7805 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0056 | 0.0456 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.0056 | 0.0456 | 0.7805 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.5013 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0584 | 1 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0056 | 0.0456 | 0.0909 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.0056 | 0.0456 | 0.7805 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0056 | 0.0456 | 0.0909 |
Schistosoma mansoni | thyroid hormone receptor | 0.0193 | 0.4652 | 0.9279 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0456 | 0.7805 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0456 | 0.7805 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0456 | 0.7805 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.0056 | 0.0456 | 0.0909 |
Onchocerca volvulus | 0.0056 | 0.0456 | 1 | |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0163 | 0.3742 | 0.3443 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0456 | 0.7805 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0056 | 0.0456 | 0.0909 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0584 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0056 | 0.0456 | 0.7805 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0056 | 0.0456 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0193 | 0.4652 | 0.9279 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0056 | 0.0456 | 0.0909 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0056 | 0.0456 | 0.7805 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0056 | 0.0456 | 0.7805 |
Loa Loa (eye worm) | steroid hormone receptor | 0.0056 | 0.0456 | 0.7805 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0056 | 0.0456 | 0.0909 |
Schistosoma mansoni | coup transcription factor | 0.0056 | 0.0456 | 0.0909 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.5013 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.5013 | 0.4775 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0137 | 0.2934 | 0.2596 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.0056 | 0.0456 | 0.7805 |
Echinococcus multilocularis | geminin | 0.0205 | 0.5013 | 0.4775 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0456 | 0.7805 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0056 | 0.0456 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0054 | 0.0386 | 0.0771 |
Brugia malayi | nuclear receptor NHR-88 | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0056 | 0.0456 | 0.7805 |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.0056 | 0.0456 | 0.7805 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0584 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1636 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.6573 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 5.8584 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.